$47M sweet spot round size
Most of their 6 investments are in rounds between $11M and $52M
2002
Circle Pharma, Inc. raised $45M on March 17, 2020
Investors: Nextech Invest, Berkeley Catalyst Fund, Lifeforce Capital, The Column Group and shangpharm
Morphic Therapeutic raised $80M on September 25, 2018
Investors: Omega Funds, Novo Holdings, S.R. One Ltd, The Invus Group, Polaris Partners and shangpharm
APRINOIA Therapeutics raised $11M on January 16, 2018
Investors: TaiAn Technologies Corporation and shangpharm
Obsidian Therapeutics raised $50M on December 6, 2017
Investors: GV, Takeda UK Limited, Atlas Venture, Vertex Ventures HC and shangpharm
Circle Pharma, Inc. raised $4.5M on December 21, 2016
Investors: Mission Bay Capital, Lifeforce Capital and shangpharm
Morphic Therapeutic raised $52M on June 30, 2016
Investors: Omega Funds, S.R. One Ltd, Polaris Partners and shangpharm